식품의약품안전처는 26일 메트포르민의 국내 유통 원료의약품과 완제의약품을 전수 검사한 결과 완제의약품 288개 중 31개에서 'NDMA'가 기준을 초과해 검출됐다고 밝혔다.
The Ministry of Food and Drug Safety announced on the 26th that as a result of a total inspection of pharmaceutical raw materials and finished drugs of metformim distributed in Korea, "NDMA" was detected in 31 out of 288 finished drugs exceeding the standard.